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Background: Despite many ongoing, prospective studies on the topic, sepsis still remains one of the main causes of death in hospital. 
The hormone insulin-like growth factor 1 (IGF-1) has a similar molecular structure to that of insulin. IGF-1 exerts anabolic effects and 
plays important roles in both normal physiology and pathologic processes. Previous studies have observed low serum IGF-1 level in 
patients with critical illnesses. Here, we evaluated changes in IGF-1 level based on survival of septic patients.
Methods: We evaluated 140 patients with sepsis and septic shock (21 with sepsis and 119 with septic shock) admitted to the intensive 
care unit of a university-affiliated hospital in Korea. Serum IGF-1 level was measured on days 0, 1, 3, and 7. Patients with liver disease 
were excluded from this study. All data were analyzed using SPSS version 20 (SPSS Inc., Chicago, IL, USA).
Results: Patients with septic shock had significantly lower serum IGF-1 level on days 1 and 3 than patients without septic shock (p = 
0.002 and p = 0.007, respectively). Generally, there was a negative relationship between IGF-1 and serum cortisol levels; however, this 
relationship was only significant on day 3 (p = 0.029). Furthermore, renin showed significantly negative correlation with IGF-1 on day 
3 (p = 0.038). IGF-1 level did not show significant difference between survivors and non-survivors.
Conclusions: Our results showed that IGF-1 was associated with septic shock, and that the IGF-1 axis is severely disrupted in septic 
patients. Additionally, serum cortisol and renin levels were associated with IGF-1 level.
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Introduction
Sepsis is one of the most common causes of death in the medical intensive care unit (ICU).[1] Recently, large-scale, 
prospective studies of early goal-directed therapy failed to demonstrate any improvement in the mortality.[2-4] Although 
many trials have been conducted, the global mortality rate remains high, ranging from 24.0% to 30.0% for sepsis and 
from 40.0% to 70.0% for septic shock.[5,6]
During sepsis, the hypothalamic-pituitary-adrenal axis 
(HPA) is activated, leading to the release of adrenocortico-
trophic hormone. Activation of the HPA axis and release 
of cortisol are important steps in maintaining homeostasis 
in organs affected by sepsis.[7] Stress induced by critical 
illness leads to a sympathoadrenal response. In this type of 
response, the pituitary plays an important role in both im-
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munologic and metabolic homeostasis.[8] Stimulation of 
the pituitary gland by critical illness leads to the pulsatile 
release of growth hormone (GH) and insulin-like growth 
factor-1 (IGF-1) into the plasma; however, prolonged 
sepsis gradually but significantly decreases the release 
of these hormones.[9] The more severe is the sepsis, the 
greater is the decrease in the levels of these hormones.[9] 
Previous studies showed mixed clinical results regard-
ing the influence of GH/IGF-1. Some studies showed 
clinically positive effects of GH/IGF-1 administration in 
septic and surgical patients (improved nitrogen balance, 
maintenance of GH/IGF-1 level, increased bursting pres-
sure of anastomosis, and prevention of gut barrier fail-
ure), whereas other studies reported no changes or even 
increased mortality in association with GH administra-
tion.[10-14]
Although the changes in serum GH/IGF-1 level under 
septic or surgical conditions have been studied previ-
ously, changes in these hormones over time have not 
been well-evaluated. Moreover, most previous studies re-
garding GH/IGF-1 were performed in Western countries. 
As such, additional studies are needed to investigate the 
role of GH in an Asian population. Furthermore, previ-
ous studies analyzed the interaction between IGF-1 and 
the cortisol or renin-angiotensin system in the context of 
diabetes mellitus or cardiovascular disease.[15-18]
We aimed to investigate the differences and change 
over time in serum IGF-1 level in medical ICU patients 
with or without septic shock on days 0 (day of admis-
sion), 1, 3, and 7 to determine whether IGF-1 is associ-
ated with a better prognosis. Furthermore, we investi-
gated the relationships of renin and cortisol with IGF-1 
in patients with sepsis.
Materials and Methods
1) Study populations
This study was performed in the medical ICU of Sever-
ance Hospital, a 2,500-bed university medical center in 
Seoul, South Korea. The medical ICU is a 30-bed closed 
unit, managed by certified ICU specialists who care only 
for ICU patients. The cardiac ICU is operated separately. 
All patients admitted to the medical ICU were enrolled 
in this study from August 2008 to December 2008.
In this study, sepsis was defined as a systemic response 
Fig. 1. Flow chart of the study 
population. Initially, 179 intensive 
care unit (ICU) patients were en-
rolled from August to December 
2008. The following patients were 
excluded: patients who were being 
admitted for a second time (n = 4), 
patients with liver disease (n = 23), 
patients diagnosed with systemic 
inflammatory response syndrome 
(SIRS) (n = 3), and patients with 
noninfectious disease (n = 9).
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to infection that met three of the four criteria for sys-
temic inflammatory response syndrome: (1) body tem-
perature less than 36°C or greater than 38°C; (2) heart 
rate greater than 90 beats per minute; (3) respiratory rate 
greater than 20 breaths per minute or a PaCO2 less than 
32 mmHg; and (4) white blood cell count less than 4,000 
cells/mm³ or greater than 12,000 cells/mm³. Septic shock 
was defined as sepsis-related persistent hypotension, de-
spite adequate fluid resuscitation.[19] A total of 179 ICU 
patients were initially enrolled. Patients were excluded 
if they were younger than 18 years of age, pregnant, or 
readmitted to the ICU during their hospital stay. Patients 
who required primary cardiac treatment, had liver disease 
(e.g., immune hepatitis, hepatitis B/C, liver cirrhosis, 
hepatocellular carcinoma), or did not meet the criteria 
for sepsis were also excluded. Finally, 140 ICU patients 
were analyzed; 21 patients had sepsis without shock, and 
119 patients had sepsis with shock (Fig. 1).
The guidelines of the Surviving Sepsis Campaign were 
used for management of the study population.[20] For 
each patient, age, sex, body mass index (BMI), PaO2/
FiO2 ratio, infection site, comorbidity, length of ICU stay, 
and 28-day mortality were investigated. Various labora-
tory parameters, including IGF-1 level, were analyzed 
on days 0 (day of ICU admission), 1, 3, and 7. Addition-
ally, Acute Physiology and Chronic Health Evaluation 
(APACHE) II and Sequential Organ Failure Assessment 
(SOFA) scores were calculated.
2) Blood sampling and assays
After admission to the medical ICU (day 0), arterial 
catheterization was performed by a resident physician. 
Initial blood samples were obtained immediately using 
an indwelling arterial catheter. The remaining blood sam-
ples (days 1, 3, and 7) were obtained at 5:00 AM for all 
eligible patients. Serum IGF-1 level and renin were mea-
sured using a commercial radioimmunoassay kit (Diaso-
rin, Stillwater, MN, USA). Cortisol level was measured 
with a competitive binding immunoenzymatiic assay kit 
(Beckman Coulter, Miami, FL, USA).
3) Statistical analysis
The Mann–Whitney U test or Student’s t-test was used 
for analysis depending on data distribution. Quantita-
tive data are reported as median with interquartile range 
or mean ± standard deviation. Fisher’s exact test or 
Pearson’s 2 test was used for the analysis of categorical 
variables, which are reported as absolute frequencies 
and percentages. After adjusting for age, sex, and BMI, 
a linear mixed model was used to analyze changes in 
IGF-1 level over time in septic patients with or without 
shock. Pearson’s correlation analyses were performed to 
evaluate relationships between cortisol, renin, aldoste-
rone, glucagon, and IGF-1 level. The effect of IGF-1 on 
28-day mortality after adjusting for age, sex, and BMI 
was analyzed using Cox proportional hazards regression 
models. All statistical analyses in this study were con-
ducted using SPSS™ version 20 software (SPSS Inc., 
Chicago, IL, USA). An adjusted p-value < 0.05 was de-
fined as statistically significant.
4) Ethics statement
The study protocol was reviewed and approved by the 
Institutional Review Board of Yonsei University Health 
Service, Severance Hospital (IRB approval No. 4-2008-
0099). Written consent was obtained from the patients or 
their relatives.
Results
Table 1 shows the baseline characteristics of the study 
population (n = 140) on the day of admission. The mean 
age of the enrolled patients was 62.3 ± 16.0 years, and 
the mean BMI was 23.1 ± 4.0 kg/m2. Age, sex, BMI, and 
length of ICU stay did not significantly differ between 
septic patients with shock and those without shock. 
Patients with septic shock had significantly elevated 
APACHE II and SOFA scores relative to those of sepsis 
patients without shock (p = 0.008 and < 0.001, respec-
tively). The most common infection site was lung (83.6%) 
followed by abdomen (10.0%) in both groups, and the 
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differences between the groups were not significant (p 
= 0.932). Comorbidities were not significantly different 
between the groups. Understandably, mortality was sig-
nificantly higher in patients with septic shock (p < 0.001).
Many of the laboratory results at admission are listed 
in Table 2. Hemoglobin level, platelet count, and renal 
function (blood urea nitrogen and creatinine levels) did 
not differ significantly between the groups (p = 0.741, 
0.794, 0.457, and 0.924, respectively). Among patients 
with sepsis, shock was associated with significantly el-
evated C-reactive protein level and significantly reduced 
albumin level (p = 0.007 and 0.004, respectively). A not 
significant difference in serum IGF-1 level was observed 
between the groups. Furthermore, there were no signifi-
cant differences in serum levels of many other hormones 
on the day of ICU admission.
Fig. 2 shows the changes in serum IGF-1, cortisol, and 
renin levels over time from the day of ICU admission to 
ICU day 7. After adjusting for age, sex, and BMI, these 
changes did not differ significantly between septic pa-
tients with shock and those without (p = 0.277, 0.208, 
and 0.165, respectively). However, significant differenc-
es in mean IGF-1 level were observed on days 1 and 3 (p 
= 0.002 and 0.007, respectively). In addition, the groups 
differed significantly in serum cortisol level on days 1, 
3, and 7 and in serum renin level on day 3. A Cox pro-
Table 1. Baseline characteristics of patients at ICU admission (n = 140, day 0)
Variables
Sepsis without shock
(n = 21)
Sepsis with shock
(n = 119)
p-value
Age (yr) 58.2 ± 18.1 63.0 ± 15.5 0.203
Male 16 (76.2) 70 (58.8) 0.132
BMI (kg/m2) 23.0 ± 3.7 23.1 ± 4.1 0.962
Length of ICU stay (days) 7.0 [4.5, 14.5] 11.0 [5.0, 21.0] 0.147
APACHE II score 16.2 ± 6.6 19.7 ± 5.1 0.008
SOFA score 4.3 ± 2.1 8.2 ± 3.5 < 0.001
PaO2/FiO2 (mmHg) 266.3 ± 136.6 212.8 ± 110.7 0.051
Infection site 0.932
Lung 17 (81.0) 100 (84.0)
Urinary tract 1 (4.8) 4 (3.4)
Abdomen 2 (9.5) 12 (10.1)
Others 1 (4.8) 3 (2.5)
Underlying diseases
Diabetes mellitus 3 (14.3) 32 (26.9) 0.219
Chronic lung disease* 5 (23.8) 24 (20.2) 0.704
Chronic renal disease 4 (19.0) 17 (14.3) 0.522
Hypertension 10 (47.6) 47 (39.5) 0.485
Heart failure 5 (23.8) 12 (10.1) 0.137
Coronary artery disease 2 (9.5) 13 (10.9) 1.000
Mortality 1/20 (4.8) 62/57 (52.1) < 0.001
Data are presented as mean ± SD or numbers (percentages).
ICU: intensive care unit; BMI: body mass index; APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment.
*Chronic lung disease includes asthma, chronic obstructive pulmonary disease, and structural lung diseases, such as bronchiectasis and interstitial lung disease.
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Table 2. Laboratory data of patients at ICU admission (n = 140, day 0)
Variables
Sepsis without shock
(n = 21)
Sepsis with shock
(n = 119)
p-value
Hemoglobin (g/dL) 10.1 ± 2.7 9.9 ± 2.2 0.741
Platelets (103/mm3) 201.0 ± 118.8 191.6 ± 157.2 0.794
Blood urea nitrogen (mg/dL) 26.9 ± 20.4 31.3 ± 25.3 0.457
Creatinine (mg/dL) 1.9 ± 2.1 1.9 ± 2.2 0.924
CRP (mg/dL) 14.0 ± 7.1 19.5 ± 12.9 0.007
Albumin (mg/dL) 3.1 ± 0.7 2.6 ± 0.6 0.004
Cholesterol (mg/dL) 128.2 (112.5, 148.5) 97.1 (63.0, 120.0) 0.004
Triglyceride (mg/dL) 179.1 (62.0, 302.3) 106.8 (61.3, 130.3) 0.152
IGF-1 (ng/mL) 96.5 (46.6, 137.0) 47.9 (27.8, 89.9) 0.092
Cortisol (ug/dL) 29.8 (15.4, 37.7) 31.3 (20.2, 47.5) 0.213
Renin (ng/mL/hr) 2.9 (0.5, 13.9) 4.7 (0.9, 15.8) 0.941
Aldosterone (pg/mL) 82.4 (44.3, 170.3) 89.3 (42.9, 165.8) 0.962
Glucagon (pg/mL) 50.5 (45.3, 61.0) 67.0 (42.0. 132.0) < 0.001
Data are presented as mean ± SD or median (interquartile range).
ICU: intensive care unit; CRP: C-reactive protein; IGF-1: insulin-like growth factor-1.
Fig. 2. Time course of insulin-like growth factor (IGF-1), 
cortisol, and renin levels in patients with sepsis and septic 
shock. Data for IGF-1 (A), cortisol (B), and renin (C) are 
shown. The values were examined on the day of admis-
sion (day 0) and on days 1, 3, and 7. The circles represent 
the mean, and the bars represent the standard error of the 
mean. *Significant differences between the sepsis patients 
and the septic shock patients.
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portional hazards model was used to evaluate the effects 
of IGF-1, cortisol, and renin levels on survival (Table 3). 
This analysis of days 0, 1, 3, and 7 was adjusted for age, 
sex, BMI, and SOFA score. With the exception of renin, 
the hormones did not significantly affect survival. How-
ever, renin only affected survival on days 1 and 7, losing 
statistical significance on days 0 and 3.
We further investigated the correlative relationship 
between IGF-1 level and cortisol, renin, aldosterone, and 
glucagon levels (Table 4). Serum cortisol level consis-
tently showed a negative correlation with IGF-1 level, 
and this was significant on day 3 (p = 0.029). The other 
hormones showed no distinct correlation with IGF-1 
level.
Discussion
This study investigated changes in serum IGF-1, cor-
tisol, and renin levels over time in a Korean population 
with sepsis or septic shock. Serum IGF-1 level was lower 
in patients with septic shock than in septic patients with-
out shock. Furthermore, IGF-1 level tended to have a 
negative relationship with serum cortisol level.
IGF-1 is a single-chain polypeptide hormone mainly 
produced by the liver and stimulated by pituitary GH. It 
has an anabolic effect that slows the catabolic response.
[21] IGF-1 also plays an important role in multiple as-
pects of immunity (both innate and acquired) and inflam-
matory disorders.[22]
Table 4. Correlations between IGF-1 level and serum concentra-
tions of cortisol and renin in ICU patients with sepsis
Variable Correlation (rho) p-value
Day 0 Cortisol –0.052 0.647
Renin 0.044 0.700
Aldosterone –0.015 0.896
Glucagon –0.159 0.218
Day 1 Cortisol –0.215 0.066
Renin 0.005 0.965
Aldosterone –0.087 0.456
Glucagon –0.136 0.317
Day 3 Cortisol –0.271 0.029
Renin –0.258 0.038
Aldosterone –0.052 0.684
Glucagon 0.000 0.998
Day 7 Cortisol –0.221 0.140
Renin –0.135 0.382
Aldosterone 0.068 0.659
Glucagon 0.199 0.253
IGF-1: insulin-like growth factor-1; ICU: intensive care unit.
Table 3. Survival analysis for IGF-1, cortisol, and renin adjusting for age, sex, body mass index, and Sequential Organ Failure Assess-
ment score
Variables Median (IQR) Hazard ratio 95% CI p-value
Day 0 IGF-1 55.3 (30.7, 96.9) 1.004 0.996-1.011 0.327
Cortisol 31.1 (19.5, 46.2) 0.997 0.990-1.004 0.422
Renin 3.8 (0.7, 15.2) 0.998 0.974-1.022 0.871
Day 1 IGF-1 57.8 (30.6, 104.2) 1.001 0.994-1.007 0.805
Cortisol 27.4 (17.6, 47.2) 1.001 0.996-1.006 0.718
  Renin 4.0 (1.2, 14.4) 1.025 1.001-1.049 0.042
Day 3 IGF-1 51.4 (29.8, 91.9) 0.996 0.987-1.005 0.402
Cortisol 23.2 (15.0, 74.5) 0.998 0.994-1.003 0.523
Renin 3.1 (0.8, 20.7) 1.023 0.997-1.049 0.084
Day 7 IGF-1 65.7 (46.1, 95.5) 1.000 0.991-1.009 1.000
Cortisol 23.9 (17.1, 49.2) 0.995 0.984-1.006 0.381
Renin 2.2 (0.5, 15.1) 1.106 1.055-1.160 < 0.001
IGF-1: insulin-like growth factor-1; IQR: interquartile range; CI: confidence interval.
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In our study, serum IGF-1 level was consistently lower 
in patients with septic shock than in sepsis patients with-
out shock; however, this was not significant on the day 
of admission or on day 7. In pro-inflammatory condi-
tions like sepsis, expression of many cytokines, includ-
ing interleukin-1 and tumor necrosis factor-α, increases 
and can induce metabolic changes. As a result, GH and 
IGF-1 levels are decreased.[23] Altered pulsatile release 
and blood sampling at a non-standard time on the day of 
admission might explain the nonsignificant difference 
between sepsis and septic shock patients on day 0.[24] 
The significant difference in IGF-1 level on days 1 and 3 
might indicate that this level increased toward normal in 
patients without shock, while it remained low in patients 
with shock. Ashare et al.[25] reported that pretreatment 
with IGF-1 or replacement of IGF-1 12 hours after infec-
tion improved hepatic bacterial clearance and overall 
survival in a mouse model. Therefore, the difference in 
IGF-1 level between the two groups in the present study 
suggests that early IGF-1 treatment could be a beneficial 
component of infection control in septic patients.
Previous studies showed mixed results when assess-
ing the effect of GH on mortality. Some studies showed 
that a high GH level was significantly associated with 
increased mortality, while other studies did not.[26-29] 
Papastathi et al.[9] showed that mortality was not related 
with IGF-1, IGF-binding protein-3, or GH level. Further-
more, they reported that GH was not a prognostic marker 
of survival. Similarly, our study showed that IGF-1 level 
on day 0, 1, 3, or 7 was not associated with survival.
However, we did observe that renin was significantly 
associated with mortality on days 1 and 7. Previous stud-
ies showed that the renin-angiotensin-aldosterone system 
(RAAS) is activated in sepsis patients, and that activated 
RAAS mediators were associated with microvascular 
dysfunction and organ disorders.[30,31] Salgado et 
al.[31] reported that administration of RAAS antagonists 
in the early phase of sepsis could protect against endo-
thelial damage and organ failure and eventually reduce 
the mortality rate. Further studies are needed to exam the 
role of renin in sepsis.
Low-dose hydrocortisone is usually administered in the 
ICU to patients with septic shock who are unresponsive 
to volume trial and vasopressor administration. How-
ever, Volbeda et al.[32] conducted a systematic review 
and meta-analyses of 35 trials, including 4,682 patients, 
and reported no statistically significant effects of ste-
roid therapy on mortality or adverse events in patients 
with systemic inflammatory response syndrome, sepsis, 
severe sepsis, or even septic shock. Our study supports 
those earlier findings. Although serum cortisol level was 
significantly different between sepsis patients and septic 
shock patients on days 1, 3, and 7, cortisol level was not 
significantly associated with mortality.
A previous study showed that IGF-1 level was nega-
tively correlated with cortisol level and sepsis severity.[9] 
IGF-1 also reduces angiotensin level and apoptosis.[33] 
In our study, IGF-1 level was significantly negatively 
correlated with both cortisol and renin levels on day 3; 
however, on the other days, these correlations were not 
significant. This could be explained by different blood 
sampling times on the day of admission and disruption 
of hormone homeostasis within approximately 1 week in 
sepsis patients.
This study has some limitations. First, we did not 
evaluate hormones that are closely related to IGF-1. GH 
and IGF-binding protein-3 levels are closely associated 
with IGF-1 level. An analysis of these hormones might 
have provided additional information about the changes 
in IGF-1 level in sepsis patients. Second, the duration of 
sepsis before ICU admission was not evaluated in this 
study. Hormone levels are severely affected by the sever-
ity and duration of sepsis. Therefore, the duration of in-
fection before ICU admission might have affected the re-
sults of our study. Well-designed prospective studies that 
consider the severity of sepsis and the duration of infec-
tion before ICU admission are therefore needed. Third, 
although we excluded patients with liver disease, we did 
not exclude those who had recently been prescribed cor-
ticosteroids or those with malignant disease or diabetes 
mellitus. While this could have affected our results, all of 
the study population was treated with an insulin protocol 
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with a targeted glucose level of 100 to 140 mg/dL, and 
their diet was managed by a specialized nutrition team.
In conclusion, we investigated whether the severity of 
sepsis was associated with changes in hormone levels in 
Korean ICU patients. Although IGF-1 level was lower in 
septic shock patients, this factor was not significantly as-
sociated with mortality. Septic shock patients also exhib-
ited higher cortisol and renin levels relative to sepsis pa-
tients. Furthermore, renin level was significantly related 
with mortality on days 1 and 7. Prospective large-scale 
studies are needed to confirm the roles of these hormones 
in ICU patients.
ORCID
Sang Hoon Lee http://orcid.org/0000-0002-7706-5318  
Kyung Soo Chung http://orcid.org/0000-0003-1604-8730  
Eun Young Kim http://orcid.org/0000-0002-3281-5744  
Ji Ye Jung http://orcid.org/0000-0003-1589-4142  
Moo Suk Park  http://orcid.org/0000-0003-0820-7615
 
References
  1) Assuncao MS, Teich V, Shiramizo SC, Araújo DV, 
Carrera RM, Serpa Neto A, et al: The cost-effective-
ness ratio of a managed protocol for severe sepsis. J 
Crit Care 2014; 29: 692.e1-6.
  2) Mouncey PR, Osborn TM, Power GS, Harrison DA, 
Sadique MZ, Grieve RD, et al: Trial of early, goal-
directed resuscitation for septic shock. N Engl J Med 
2015; 372: 1301-11.
  3) ARISE Investigators; ANZICS Clinical Trials Group, 
Peake SL, Delaney A, Bailey M, Bellomo R, et al: 
Goal-directed resuscitation for patients with early 
septic shock. N Engl J Med 2014; 371: 1496-506.
  4) ProCESS Investigators, Yealy DM, Kellum JA, 
Huang DT, Barnato AE, Weissfeld LA, et al: A ran-
domized trial of protocol-based care for early septic 
shock. N Engl J Med 2014; 370: 1683-93.
  5) Russell JA: Management of sepsis. N Engl J Med 
2006; 355: 1699-713.
  6) Vincent JL, Marshall JC, Namendys-Silva SA, 
François B, Martin-Loeches I, Lipman J, et al: As-
sessment of the worldwide burden of critical illness: 
the intensive care over nations (ICON) audit. Lancet 
Respir Med 2014; 2: 380-6.
  7) Zhang Q, Dong G, Zhao X, Wang M, Li CS: Prog-
nostic significance of hypothalamic-pituitary-adrenal 
axis hormones in early sepsis: a study performed 
in the emergency department. Intensive Care Med 
2014; 40: 1499-508.
  8) Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti 
EC: Systemic illness. Pituitary 2008; 11: 187-207.
  9) Papastathi C, Mavrommatis A, Mentzelopoulos S, 
Konstandelou E, Alevizaki M, Zakynthinos S: Insu-
lin-like growth factor I and its binding protein 3 in 
sepsis. Growth Horm IGF Res 2013; 23: 98-104.
10) Takala J, Ruokonen E, Webster NR, Nielsen MS, 
Zandstra DF, Vundelinckx G, et al: Increased mor-
tality associated with growth hormone treatment in 
critically ill adults. N Engl J Med 1999; 341: 785-92.
11) Donmez R, Oren D, Ozturk G, Kisaoglu A, Ozogul B, 
Atamanalp SS: The combined effects of glutamine 
and growth hormone on intestinal anastomosis in the 
rat intra-abdominal sepsis model. J Surg Res 2013; 
182: 142-5.
12) Voerman HJ, van Schijndel RJ, Groeneveld AB, de 
Boer H, Nauta JP, van der Veen EA, et al: Effects 
of recombinant human growth-hormone in patients 
with severe sepsis. Ann Surg 1992; 216: 648-55.
13) Bjarnason R, Wickelgren R, Hermansson M, Ham-
marqvist F, Carlsson B, Carlsson LM: Growth hor-
mone treatment prevents the decrease in insulin-like 
growth factor I gene expression in patients under-
going abdominal surgery. J Clin Endocrinol Metab 
1998; 83: 1566-72.
14) Yue C, Wang W, Tian WL, Huang Q, Zhao RS, Zhao 
YZ, et al: Lipopolysaccharide-induced failure of the 
gut barrier is site-specific and inhibitable by growth 
hormone. Inflamm Res 2013; 62: 407-15.
332   The Korean Journal of Critical Care Medicine: Vol. 31, No. 4, November 2016
https://doi.org/10.4266/kjccm.2016.00024
15) Jaffa AA, Vio C, Velarde V, LeRoith D, Mayfield 
RK: Induction of renal kallikrein and renin gene 
expression by insulin and IGF-I in the diabetic rat. 
Diabetes 1997; 46: 2049-56.
16) Haddad GE, Blackwell K, Bikhazi A: Regulation of 
insulin-like growth factor-1 by the renin-angiotensin 
system during regression of cardiac eccentric hyper-
trophy through angiotensin-converting enzyme in-
hibitor and AT1 antagonist. Can J Physiol Pharmacol 
2003; 81: 142-9.
17) Spicer LJ, Chamberlain CS: Influence of cortisol on 
insulin- and insulin-like growth factor 1 (IGF-1)-
induced steroid production and on IGF-1 receptors 
in cultured bovine granulosa cells and thecal cells. 
Endocrine 1998; 9: 153-61.
18) Weber MM, Simmler P, Fottner C, Engelhardt D: 
Insulin-like growth factor II (IGF-II) is more potent 
than IGF-I in stimulating cortisol secretion from 
cultured bovine adrenocortical cells: interaction with 
the IGF-I receptor and IGF-binding proteins. Endo-
crinology 1995; 136: 3714-20.
19) American-College of Chest Physicians Society of 
Critical Care Medicine Consensus Conference: defi-
nitions for sepsis and organ failure and guidelines for 
the use of innovative therapies in sepsis. Crit Care 
Med 1992; 20: 864-74.
20) Dellinger RP, Levy MM, Carlet JM, Bion J, Parker 
MM, Jaeschke R, et al: Surviving Sepsis Campaign: 
international guidelines for management of severe 
sepsis and septic shock: 2008. Crit Care Med 2008; 
36: 296-327.
21) Lin MC, Leung SY, Fang WF, Chin CH, Chung 
KF: Down-regulation of insulin-like growth fac-
tor I (IGF-I) in the mouse diaphragm during sepsis. 
Chang Gung Med J 2010; 33: 501-8.
22) Heemskerk VH, Daemen MA, Buurman WA: 
Insulin-like growth factor-1 (IGF-1) and growth hor-
mone (GH) in immunity and inflammation. Cytokine 
Growth Factor Rev 1999; 10: 5-14.
23) Dahn MS, Lange MP, Jacobs LA: Insulinlike growth 
factor-I production is inhibited in human sepsis. 
Arch Surg 1988; 123: 1409-14.
24) Van den Berghe G: Endocrine changes in critically 
ill patients. Growth Horm IGF Res 1999; 9 Suppl A: 
77-81.
25) Ashare A, Nymon AB, Doerschug KC, Morrison JM, 
Monick MM, Hunninghake GW: Insulin-like growth 
factor-1 improves survival in sepsis via enhanced he-
patic bacterial clearance. Am J Respir Crit Care Med 
2008; 178: 149-57.
26) Gianotti L, Broglio F, Aimaretti G, Arvat E, Co-
lombo S, Di Summa M, et al: Low IGF-I levels are 
often uncoupled with elevated GH levels in catabolic 
conditions. J Endocrinol Invest 1998; 21: 115-21.
27) Frayn KN, Price DA, Maycock PF, Carroll SM: 
Plasma somatomedin activity after injury in man 
and its relationship to other hormonal and metabolic 
changes. Clin Endocrinol (Oxf) 1984; 20: 179-87.
28) Schuetz P, Müller B, Nusbaumer C, Wieland M, 
Christ-Crain M: Circulating levels of GH predict 
mortality and complement prognostic scores in criti-
cally ill medical patients. Eur J Endocrinol 2009; 
160: 157-63.
29) de Groof F, Joosten KF, Janssen JA, de Kleijn ED, 
Hazelzet JA, Hop WC, et al: Acute stress response in 
children with meningococcal sepsis: important dif-
ferences in the growth hormone/insulin-like growth 
factor I axis between nonsurvivors and survivors. J 
Clin Endocrinol Metab 2002; 87: 3118-24.
30) Doerschug KC, Delsing AS, Schmidt GA, Ashare A: 
Renin-angiotensin system activation correlates with 
microvascular dysfunction in a prospective cohort 
study of clinical sepsis. Crit Care 2010; 14: R24.
31) Salgado DR, Rocco JR, Silva E, Vincent JL: Modu-
lation of the renin-angiotensin-aldosterone system 
in sepsis: a new therapeutic approach? Expert Opin 
Ther Targets 2010; 14: 11-20.
32) Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van 
der Horst ICC, Keus F: Glucocorticosteroids for sep-
sis: systematic review with meta-analysis and trial 
sequential analysis. Intensive Care Med 2015; 41: 
1220-34.
https://doi.org/10.4266/kjccm.2016.00024
Sang Hoon Lee, et al. Change in IGF-1 Level in Sepsis  333
33) Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chi-
menti S, Medow MS, et al: IGF-1 overexpression 
inhibits the development of diabetic cardiomyopathy 
and angiotensin II-mediated oxidative stress. Diabe-
tes 2001; 50: 1414-24.
